|
|
|
|
|
|
|
Navigation
News
|
 |
Statutory Instrument 2003 No. 3141The Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2003(The document as of February, 2008) STATUTORY INSTRUMENTS2003 No. 3141MEDICINESThe Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2003
As respects England, Scotland and Wales, the Secretary of State concerned with health in England and, as respects Northern Ireland, the Department of Health, Social Services and Public Safety, acting jointly as the Health Ministers, in exercise of the powers conferred on them by sections 75(1), 76(1), (2) and (6) and 129(5) of the Medicines Act 1968[1] or, as the case may be, those conferred by those provisions and now vested in them[2], and of all other powers enabling them in that behalf, after consulting such organisations as appear to them to be representative of interests likely to be substantially affected by these Regulations, pursuant to section 129(6) of that Act, hereby make the following Regulations: - Citation and commencement 1.These Regulations may be cited as the Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2003 and shall come into force on 1st January 2004. Amendment of the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 1973 2.In regulation 3 of the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 1973[3] (fees) -
(b) in paragraph (2) (retention fee), for "Ј101" substitute "Ј125" and for "Ј92" (fee where premises are in Northern Ireland) substitute "Ј112"; (c) in paragraph (3) (additional sum by way of penalty), for "Ј323" substitute "Ј336" and for "Ј240" (sum where premises are in Northern Ireland) substitute "Ј250". Revocation (This note is not part of the Regulations) These Regulations further amend the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 1973 ("the principal Regulations") as follows -
(b) regulation 2(b) increases subsequent annual fees (retention fees) from Ј101 to Ј125 (where the premises are in Great Britain) and from Ј92 to Ј112 (where the premises are in Northern Ireland); (c) regulation 2(c) increases the penalty for failure to pay retention fees (payable in circumstances specified in section 76(2) of the Medicines Act 1968) from Ј323 to Ј336 (where the premises are in Great Britain) and from Ј240 to Ј250 (where the premises are in Northern Ireland). These Regulations also revoke the Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2002, which increased the fees in the principal Regulations, the effect of which is spent on the coming into force of these Regulations. Notes: [1] 1968 c. 67; the expression "the Health Ministers" is defined in section 1(1)(a) of that Act, as amended by article 2(2) of, and Schedule 1 to, S.I. 1969/388, and by article 5 of, and paragraph 1(1) of the Schedule to, S.I. 1999/3142; the word "prescribed" is defined in section 132(1) of that Act.back [2] In the case of the Secretary of State concerned with health in England, by virtue of article 2(2) of, and Schedule 1 to, S.I.1969/388, and by articles 2(1) and 5 of, and paragraph 1(1) of the Schedule to, S.I. 1999/3142; and in the case of the Department of Health, Social Services and Public Safety, the powers vested in the Minister in charge of that Department by virtue of section 95(5) of, and paragraph 10 of Schedule 12 to, the Northern Ireland Act 1998 (c. 47) may now be exercised by the Department by virtue of section 1(8) of, and paragraph 4(1)(b) of the Schedule to, the Northern Ireland Act 2000 (c. 1); the Department was renamed by virtue of Article 3(6) of S.I. 1999/283 (N.I.1.).back [3] S.I. 1973/1822; the relevant amending instruments are S.I. 1980/1806 and S.I. 2002/3024.back [4] S.I. 2002/3024back ISBN 0 11 048266 2 -- Back --
Stat
| |
Other
|